Ziylo Founder Dr Harry Destecroix Voted Bessemer Fellow of 2018

Ziylo was recently acquired in a deal worth up to $800m, giving rights of its glucose-binding molecules to Novo Nordisk Dr Harry Destecroix progressed through the SETsquared incubation programme with Ziylo, which he founded as a University of Bristol spin out in 2015 Bessemer Fellowship is awarded to the person who exhibits tenacity, drive, ambition,…

Read More